Altimmune, Inc.
(NASDAQ : ALT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ULTIUltimate Software Group, Inc.
0.15%332.549.9%$311.84m
EFXEquifax Inc.
-0.15%110.322.0%$139.24m
FLTFleetCor Technologies, Inc.
1.01%228.023.4%$136.99m
ETSYEtsy, Inc.
6.05%56.247.9%$135.69m
XRXXerox Corporation
0.26%31.415.8%$130.72m
ITGartner, Inc.
0.43%142.412.4%$124.18m
ZZillow Group, Inc. Class C
23.26%43.1910.3%$110.27m
CDKCDK Global Inc
0.19%58.152.3%$95.86m
TRUTransUnion
0.32%63.360.9%$94.10m
CTASCintas Corporation
0.62%204.244.6%$85.72m
KARKAR Auction Services, Inc.
-2.10%47.101.4%$68.57m
CPRTCopart, Inc.
2.80%58.124.5%$65.64m
BAHBooz Allen Hamilton Holding Corporation Class A
1.01%54.202.0%$56.59m
BZUNBaozun Inc Sponsored ADR Class A
6.39%36.791.7%$55.43m
MDSOMedidata Solutions, Inc.
1.09%75.797.5%$42.20m

Company Profile

Altimmune, Inc. is a clinical stage company, which engages in the research and development of immunotherapeutic products. Its portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. The company was founded in 1997 and is headquartered in Gaithersburg, MD.